RHOA and melanoma: In conclusion, we have demonstrated a direct inhibitory effect of ropivacaine and lidocaine but not bupivacaine on melanoma cells, which are associated with sodium channel-independent inhibition of Ras and RhoA signaling (Supplementary Fig. 12).